European Child & Adolescent Psychiatry

, Volume 16, Issue 4, pp 243–253 | Cite as

Consequences of prenatal toxin exposure for mental health in children and adolescents

A systematic review
ORIGINAL CONTRIBUTION

Abstract

Drug use during pregnancy is common and the developing foetus may be exposed to a range of environmental toxins that have long-term consequences for neurodevelopment. We conducted a systematic review of the literature to explore the results of longitudinal cohort studies that have examined this question. Out of 2,977 abstracts identified, 7 previous systematic reviews and 95 original articles met further selection criteria. These mostly addressed the neurodevelopmental effects of exposure to lead, polychlorinated biphenyls, mercury, cocaine, alcohol, marijuana, cigarettes and antidepressants. Radiation, opiates, steroids, amphetamines and caffeine have received much less attention. Findings are difficult to interpret because risk factors tend to cluster together and interact. However, some findings are consistent. Lead and PCB’s have a general effect on brain development, whilst marijuana and alcohol appear to have long-term effects specifically on attentional skills. The effects of alcohol increase with maternal age and binge drinking is more important than average intake. The effects of cocaine diminish with age and are largely mediated through psychosocial factors, whilst the relation between smoking and later delinquency is largely mediated by genetically inherited factors. Exposure to toxins during pregnancy may constitute an important but relatively unacknowledged cause of child psychiatric morbidity.

Keywords

prenatal toxins child adolescent neuro-development mental health ADHD psychiatric disorder risk factor intra-uterine 

Supplementary material

References

  1. 1.
    Charman T (2002) The prevalence of autistic spectrum disorders—recent evidence and future challenges. Eur Child Adolesc Psychiatry 11:249–256PubMedCrossRefGoogle Scholar
  2. 2.
    Fombonne E (2003) Epidemiological surveys of autism and other pervasive developmental disorders. J Autism Dev Disord 33:365–382PubMedCrossRefGoogle Scholar
  3. 3.
    Rasmussen P, Gillberg C (2000) Natural outcome of ADHD with developmental co-ordination disorder at age 22 years: a controlled longitudinal community-based study. J Am Acad Child Adolesc Psychiatry 39:1424–1431PubMedCrossRefGoogle Scholar
  4. 4.
    de Weerth C, Buitelaar JK, Mulder EJH (2005) Prenatal programming of behavior, physiology and cognition. Neurosci Behav Rev 29:207–208Google Scholar
  5. 5.
    Manning JT, Baron-Cohen S, Wheelwright S, Sanders G (2001) The 2nd to 4th digit ratio and autism. Dev Med Child Neurol 43:160–164PubMedCrossRefGoogle Scholar
  6. 6.
    Owen D, Andrews MH, Matthews SG (2005) Maternal adversity, glucocorticoids and programming of neuroendocrine function and behaviour. Neurosci Behav Rev 29:209–226Google Scholar
  7. 7.
    Van den Bergh BRH et al (2005) Antenatal maternal anxiety and stress and the neurobehavioural development of the fetus and child: links and possible mechanisms. A review. Neurosci Behav Rev 29:237–258Google Scholar
  8. 8.
    Williams JHG, Greenhalgh KD, Manning JT (2003) Second to fourth finger ratio and possible precursors of developmental psychopathology in preschool children. Early Hum Dev 72:57–65PubMedCrossRefGoogle Scholar
  9. 9.
    Davies S, Heyman I, Goodman R (2003) A population survey of mental health problems in children with epilepsy. Dev Med Child Neurol 45:292–295PubMedCrossRefGoogle Scholar
  10. 10.
    Goodman R, Graham P (1996) Psychiatric problems in children with hemiplegia: cross sectional epidemiological survey. Br Med J 312:1065–1069Google Scholar
  11. 11.
    Nordin V, Gillberg C (1996) Autism spectrum disorders in children with physical or mental disability or both. 1. Clinical and epidemiological aspects. Dev Med Child Neurol 38:297–313PubMedCrossRefGoogle Scholar
  12. 12.
    Steffenburg S, Gillberg C, Steffenburg U (1996) Psychiatric disorders in children and adolescents with mental retardation and active epilepsy. Arch Neurol 53:904–912PubMedGoogle Scholar
  13. 13.
    US Dept of Health and Human Services. Substance use during pregnancy: 2002 and 2003 Update. 2-6-2005Google Scholar
  14. 14.
    Haslam C, Lawrence W (2004) Health-related behavior and beliefs of pregnant smokers. Health Psychol 23:486–491PubMedCrossRefGoogle Scholar
  15. 15.
    Jacobson SW, Jacobson JL, Sokol RJ, Chiodo LM, Corobana R (2004) Maternal age, alcohol abuse history, and quality of parenting as moderators of the effects of prenatal alcohol exposure on 7.5-year intellectual function. Alcohol Clin Exp Res 28:1732–1745PubMedCrossRefGoogle Scholar
  16. 16.
    Pichini S, Puig C, Zuccaro P, Marchei E, Pellegrini M, Murillo J, Vall O, Pacifici R, Garcia-Algar O (2005) Assessment of exposure to opiates and cocaine during pregnancy in a Meditteranean city: preliminary results of the “meconium” project. Forensic Sci Int 153:59–65PubMedCrossRefGoogle Scholar
  17. 17.
    Zuccato E, Chiabrando C, Castiglioni S, Calamari D, Bagnati R, Schiarea S, Fanelli R (2005) Cocaine in surface waters: a new evidence-based tool to monitor community drug abuse. Environ Health 4:14 file://H\1476-069X-4-14.pdfGoogle Scholar
  18. 18.
    World Health Organization (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health OrganizationGoogle Scholar
  19. 19.
    Eskenazi B, Castorina R (1999) Association of prenatal maternal or postnatal child environmental tobacco smoke exposure and neurodevelopmental and behavioral problems in children. Environ Health Perspect 107:991–1000PubMedGoogle Scholar
  20. 20.
    Ribas-Fito N, Sala M, Kogevinas M, Sunyer J (2001) Polychlorinated biphenyls (PCBs) and neurological development in children: a systematic review. J Epidemiol Community Health 55:537–546PubMedCrossRefGoogle Scholar
  21. 21.
    Goldstein DJ, Sundell K (1999) A review of the safety of selective serotonin reuptake inhibitors during pregnancy. Hum Psychopharmacol 14:319–324CrossRefGoogle Scholar
  22. 22.
    Peterson LM, Burns WJ, Widmayer SM (1995) Developmental risk for infants of maternal cocaine abusers: evaluation and critique. Clin Psychol Rev 15:739–776CrossRefGoogle Scholar
  23. 23.
    Frank D, Augustyn M, Knight W, Pell T, Zarin D, Frank E (2001) Growth, development and behavior in early childhood following prenatal cocaine exposure. J Am Med Assoc 285:1613–1625CrossRefGoogle Scholar
  24. 24.
    Wisner KL, Gelenberg AJ, Leonard H, Zarin D, Frank E (1999) Pharmacologic treatment of depression during pregnancy. J Am Med Assoc 282:1264–1269CrossRefGoogle Scholar
  25. 25.
    Pocock SJ, Smith M, Baghurst P (1994) Environmental lead and children’s intelligence: a systematic review of the epidemiological evidence. Br Med J 309:1189–1197Google Scholar
  26. 26.
    Bellinger D, Leviton A, Allred E, Rabinowitz M (1994) Pre- and postnatal lead exposure and behavior problems in school-aged children. Environmental Research 66:12–30PubMedCrossRefGoogle Scholar
  27. 27.
    Dietrich KN, Ris MD, Succop PA, Berger OG, Bornschein RL (2001) Early exposure to lead and juvenile delinquency. Neurotoxicology & Teratology 23:511–518CrossRefGoogle Scholar
  28. 28.
    Ris MD, Dietrich KN, Succop PA, Berger OG, Bornschein RL (2004) Early exposure to lead and neuropsychological outcome in adolescence. J Int Neuropsychol Soc 10:261–270PubMedCrossRefGoogle Scholar
  29. 29.
    Tong S, Baghurst P, McMichael A, Sawyer M, Mudge J (1996) Lifetime exposure to environmental lead and children’s intelligence at 11–13 years: The Port Pirie cohort study. British Medical Journal 312:1569–1575PubMedGoogle Scholar
  30. 30.
    Wasserman GA, Graziano JH, Factor-Litvak P, Popovac D (1995) Consequences of lead exposure and iron supplementation on childhood development at age 4 years. Neurotoxicology & Teratology 16:233–240CrossRefGoogle Scholar
  31. 31.
    Serbin LA, Peters PL, McAffer VJ, Schwartzman AE (1991) Childhood aggression and withdrawal as predictors of adolescent pregnancy, early parenthood and environmental risk for the next generation. Can J Behav Sci 23:318–331CrossRefGoogle Scholar
  32. 32.
    Lai TJ, Liu X, Guo YL, Guo NW, Yu ML, Hsu CC, Rogan WJ (2002) A cohort study of behavioral problems and intelligence in children with high prenatal polychlorinated biphenyl exposure. Arch Gen Psychiatry 59:1061–1066PubMedCrossRefGoogle Scholar
  33. 33.
    Jacobson JL, Jacobson SW (2003) Prenatal exposure to polychlorinated biphenyls and attention at school age. J Pediatr 143:780–788PubMedCrossRefGoogle Scholar
  34. 34.
    Myers GJ, Davidson PW, Cox C, Shamlaye CF, Palumbo D, Cernichiari E, Sloane-Reeves J, Wilding GE, Kost J, Huang LS, Clarkson TW (2003) Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study. Lancet 361:1686–1692PubMedCrossRefGoogle Scholar
  35. 35.
    Grandjean P, Weihe P, White RF, Debes F, Araki S, Yokoyama K, Murata K, Sorensen N, Dahl R, Jorgensen PJ (1997) Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 19:417–428PubMedCrossRefGoogle Scholar
  36. 36.
    Davidson PW, Myers GJ, Shamlaye C, Cox C, Wilding GE (2004) Prenatal exposure to methylmercury and child development: influence of social factors. Neurotoxicol Teratol 26:553–559PubMedCrossRefGoogle Scholar
  37. 37.
    Croen L, Yoshida C, Odouli R, Grether J (2005) Maternal psychiatric history, antidepressant use during pregnancy, and childhood autism. Proceedings of the International Meeting for Autism Research. S1.5. Boston, May 5th–7thGoogle Scholar
  38. 38.
    Dean JCS, Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, Little J (2002) Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 39:251–259PubMedCrossRefGoogle Scholar
  39. 39.
    Rasalam AD, Hailey H, Williams JHG, Moore SJ, Turnpenny PD, Lloyd DJ, Dean JCS (2005) Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 47:551–555PubMedCrossRefGoogle Scholar
  40. 40.
    French NP, Hagan R, Evans SF, Mullan A, Newnham JP (2004) Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. Am J Obstet Gynecol 190:588–595PubMedCrossRefGoogle Scholar
  41. 41.
    Silberg JL, Parr T, Neale MC, Rutter M, Angold A, Eaves LJ (2003) Maternal smoking during pregnancy and risk to boys’ conduct disturbance: an examination of the causal hypothesis. Biol Psychiatry 53:130–135PubMedCrossRefGoogle Scholar
  42. 42.
    Maughan B, Taylor A, Caspi A, Moffitt TE (2004) Prenatal smoking and early childhood conduct problems: testing genetic and environmental explanations of the association. Arch Gen Psychiatry 61:836–843PubMedCrossRefGoogle Scholar
  43. 43.
    Fried PA, Watkinson B (2001) Differential effects on facets of attention in adolescents prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol 23:421–430PubMedCrossRefGoogle Scholar
  44. 44.
    Wakschlag LS, Hans SL (2002) Maternal smoking during pregnancy and conduct problems in high-risk youth: a developmental framework. Dev Psychopathol 14:351–369PubMedCrossRefGoogle Scholar
  45. 45.
    Batstra L, Hadders-Algra M, Neeleman J (2003) Effect of antenatal exposure to maternal smoking on behavioural problems and academic achievement in childhood: prospective evidence from a Dutch birth cohort. Early Hum Dev 75:21–33PubMedCrossRefGoogle Scholar
  46. 46.
    Weissman MM, Warner V, Wickramaratne PJ, Kandel DB (1999) Maternal smoking during pregnancy and psychopathology in offspring followed to adulthood. J Am Acad Child Adolesc Psychiatry 38:892–899PubMedCrossRefGoogle Scholar
  47. 47.
    Fried PA (1995) The Ottawa Prenatal Prospective Study (OPPS): methodological issues and findings: it’s easy to throw the baby out with the bath water. Life Sci 56:2159–2168PubMedCrossRefGoogle Scholar
  48. 48.
    Fried PA, Watkinson B, Gray R (1998) Differential effects on cognitive functioning in 9- to 12-year olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol 20:293–306PubMedCrossRefGoogle Scholar
  49. 49.
    Fried PA, Watkinson B, Gray R (1992) A follow-up study of attentional behavior in 6-year-old children exposed prenatally to marijuana, cigarettes, and alcohol. Neurotoxicol Teratol 14:299–311PubMedCrossRefGoogle Scholar
  50. 50.
    Fried AP, Watkinson B, Siegel LS (1997) Reading and language in 9- to 12-year olds prenatally exposed to cigarettes and marijuana. Neurotoxicol Teratol 19:171–183PubMedCrossRefGoogle Scholar
  51. 51.
    Caldwell B, Bradley R (1984) Home observation for measurement of the environment (HOME), Revised Edition University of Arkansas: Little Rock http://www.ualr.edu/%7ecrtldept/home4.htm
  52. 52.
    Streissguth AP, Barr HM, Sampson PD, Bookstein FL (1994) Prenatal alcohol and offspring development: the first 14 years. Drug Alcohol Depend 36:89–99PubMedCrossRefGoogle Scholar
  53. 53.
    Goldschmidt L, Richardson GA, Stoffer DS, Geva D, Day NL (1996) Prenatal alcohol exposure and academic achievement at age six: a nonlinear fit. Alcohol Clin Exp Res 20:763–770PubMedCrossRefGoogle Scholar
  54. 54.
    Bailey BN, Delaney-Black V, Covington CY, Ager J, Janisse J, Hannigan JH, Sokol RJ (2004) Prenatal exposure to binge drinking and cognitive and behavioral outcomes at age 7 years. Am J Obstet Gynecol 191:1037–1043PubMedCrossRefGoogle Scholar
  55. 55.
    Guerri C, Riley E, Strömland K (1999) Commentary on the recommendations of the Royal College of Obstetricians and Gynaecologists concerning alcohol consumption in pregnancy. Alcohol Alcohol 34(4):497–501PubMedGoogle Scholar
  56. 56.
    Goldschmidt L, Day NL, Richardson GA (2000) Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol 22:325–336PubMedCrossRefGoogle Scholar
  57. 57.
    Singer LT, Arendt R, Minnes S, Salvator A, Siegel AC, Lewis BA (2001) Developing language skills of cocaine-exposed infants. Pediatrics 107:1057–1064PubMedCrossRefGoogle Scholar
  58. 58.
    Singer LT, Arendt R, Minnes S, Farkas K, Salvator A, Kirchner HL, Kliegman R (2002) Cognitive and motor outcomes of cocaine-exposed infants. J Am Med Assoc 287: 1952–1960CrossRefGoogle Scholar
  59. 59.
    Singer LT, Minnes S, Short E, Arendt R, Farkas K, Lewis B, Klein N, Russ S, Min MO, Kirchner HL (2004) Cognitive outcomes of preschool children with prenatal cocaine exposure. J Am Med Assoc 291:2448–2456CrossRefGoogle Scholar
  60. 60.
    Singer L, Arendt R, Farkas K, Minnes S, Huang J, Yamashita T (1997) Relationship of prenatal cocaine exposure and maternal postpartum psychological distress to child developmental outcome. Dev Psychopathol 9:473–489PubMedCrossRefGoogle Scholar
  61. 61.
    Messinger DS, Bauer CR, Das A, Seifer R, Lester BM, Lagasse LL, Wright LL, Shankaran S, Bada HS, Smeriglio VL, Langer JC, Beeghly M, Poole WK (2004) The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through 3 years of age. Pediatrics 113:1677–1685PubMedCrossRefGoogle Scholar
  62. 62.
    Wesseling J, Van Driel D, Heymans HS, Rosendaal FR, Geven-Boere LM, Smrkovsky M, Touwen BC, Sauer PJ, Van der Veer E (2001) Coumarins during pregnancy: long-term effects on growth and development of school-age children. Thromb Haemost 85:609–613PubMedGoogle Scholar
  63. 63.
    Nyagu AI, Loganovsky KN, Loganovskaja TK (1998) Psychophysiologic aftereffects of prenatal irradiation. Int J Psychophysiol 30:303–311PubMedCrossRefGoogle Scholar
  64. 64.
    Viggedal G, Hagberg BS, Laegreid L, Aronsson M (1993) Mental development in late infancy after prenatal exposure to benzodiazepines: a prospective study. J Child Psychol Psychiatry 34:295–305PubMedCrossRefGoogle Scholar
  65. 65.
    Eriksson M, Jonsson B, Steneroth G, Zetterstrom R (2000) Amphetamine abuse during pregnancy: environmental factors and outcome after 14–15 years. Scand J Public Health 28:154–157PubMedCrossRefGoogle Scholar
  66. 66.
    Barr HM, Streissguth AP (1991) Caffeine use during pregnancy and child outcome: a 7-year prospective study. Neurotoxicol Teratol 13:441–448PubMedCrossRefGoogle Scholar
  67. 67.
    Moe V (2002) Foster-placed and adopted children exposed in utero to opiates and other substances: prediction and outcome at four and a half years. J Dev Behav Pediatr 23:330–339PubMedGoogle Scholar
  68. 68.
    Slinning K (2004) Foster placed children prenatally exposed to poly-substances—attention-related problems at ages 2 and 4 1/2. Eur Child Adolesc Psychiatry 13:19–27PubMedCrossRefGoogle Scholar
  69. 69.
    van Baar AL, Soepatmi S, Gunning WB, Akkerhuis GW (1994) Development after prenatal exposure to cocaine, heroin and methadone. Acta Paediatr Suppl 404:40–46PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag 2007

Authors and Affiliations

  1. 1.Department of Child HealthUniversity of Aberdeen Medical School, Royal Aberdeen Children’s HospitalAberdeenUK

Personalised recommendations